News

Izmir Biomedicine and Genome Center (IBG): Research in life sciences in Turkey

Published on: 11/01/2024

Izmir Biomedicine and Genome Center (IBG): Research in life sciences in Turkey
Learn more about Izmir Biomedicine and Genome Center (IBG), the newest member to join our gobal community.
Partnerships and Growth
Member News

Izmir Biomedicine and Genome Center (IBG) is the first independent thematic Research Infrastructure in life sciences in Izmir, Türkiye. IBG’s main objective is to carry out powerful research on biomedicine and genome sciences, to develop products based on medical and pharmaceutical biotechnologies using its workforce and technical infrastructure, and thus, to contribute to global science and the transformation of national industry. IBG offers a broad range of research services for both academia and industry across various research fields under the below core facilities and technology platforms; Gene Targeting and Transgenic Models Platform, IBG-BIP, Bioinformatics Platform, IBG-Biobank, National node of BBMRI-ERIC, IBG-PHARMA, Drug Analysis and Control Laboratory, GLP-certified, IBG-NEVCELL, Cellular Therapies Platform, GMP Manufacturing Facility, Vivarium (Zebrafish &Rodent Unit), Rare and Undiagnosed Disease Platform. IBG has been coordinating two national high-technology platforms specializing in the design of novel adjuvants and vaccines, drug development and pan-cancer therapies.

 

As of 2023, IBG hosts 32 research groups in three main pillars (i) Basic and translational research program, (ii) Technological research program, (iii) Industrial R&D program with a research focus in the fields of cancer, genomics and bioinformatics, stem cells and regeneration, immunology and infectious diseases, rare and undiagnosed diseases, neuroscience and bioengineering.

 

IBG believes that fostering strong connections and collaborations is crucial for the success of our collective initiatives. IBG is interested in leveraging the diverse expertise within the ECHAlliance community to facilitate knowledge exchange, collaborative projects, and the sharing of best practices. Establishing robust networking channels would enable them to collectively address challenges, explore innovative solutions, and contribute to the advancement of healthcare and digital health initiatives. IBG looks forward to engaging with fellow members to build meaningful connections and collaborations that will benefit the entire community.

NEWS​

Related News

New Round Tables announced to drive progress on EHDS and health AI

3 Jul 2025

The European Accessibility Act Is Here. Are You Ready?

2 Jul 2025
Why inclusive design is no longer optional – and how Big Motive can help you lead the way.

DTH-Lab Director: The G7 must act now to address the digital health transformation

2 Jul 2025
As digital platforms increasingly shape health systems and information flows, the G7 must lead in setting global standards to ensure safety, equity an...

InnoHSupport Open Calls

1 Jul 2025
Welcome to the InnoHSupport Open Calls!

Transformative Health Instrument Call 2025

1 Jul 2025
Apply to the Transformative Health Instrument (THI) Call 2025 if you are a growing and innovative healthcare start-up working on solutions that have s...

Longitude Prize on ALS

1 Jul 2025
The £7.5 million (~$10 million) Longitude Prize on ALS incentivises the use of AI-based approaches to transform drug discovery for amyotrophic lateral...

Become a member

Join ECHAlliance to amplify your organisation’s message, grow your networks, connect with innovators and collaborate globally.
 
First name *
Last Name *
Email Address *
Country *
Position *
First name *
Last Name *
Email Address *
Country *
Position *